SCHUCHERT JOSEPH S

Joseph S. Schuchert is a private equity executive affiliated with Kelso & Company in New York, appearing as a Section 16 reporting person and 10% owner representative for Kelso-managed investment vehicles. His SEC filings name him in connection with portfolio companies including Earle M. Jorgensen Company, FairPoint Communications and Endo Health Solutions.^[1]

Career Background

• Representative of Kelso & Company on Section 16 filings, acting as a reporting person for Kelso investment vehicles.^[1]
• Named on Form 3/Form 4 filings that identify him as a Director and 10% owner representative for Earle M. Jorgensen Company.^[2]
• Identified in registration and proxy-related SEC materials linking Kelso-managed funds to FairPoint Communications, with Schuchert listed among Kelso-affiliated reporting individuals.^[3]
• Listed on Section 16 filings for Endo (formerly Endo Pharmaceuticals / Endo Health Solutions) as a Kelso-affiliated reporting person and 10% owner representative.^[4]

Current Positions

• Section 16 reporting person and 10% owner representative for Kelso-managed investment vehicles that hold or held interests in portfolio companies.^[1]
• Named on SEC filings as the Kelso-affiliated reporting individual for issuer filings tied to Earle M. Jorgensen Company (issuer).^[2]
• Named on SEC filings as a Kelso-affiliated reporting individual for issuer filings tied to FairPoint Communications (ticker: FRP) and Endo (historical ticker: ENDP).^[3]

SEC Filing Context

• Public Section 16 filings associated with Mr. Schuchert show extensive Form 3/4 activity as the reporting person for Kelso investment vehicles; filings reflect substantial transactional volume across multiple portfolio issuers.^[1]
• Kelso & Company is documented as the investment manager/affiliate behind the reporting group named on these filings, providing the corporate context for Schuchert’s reporting role.^[5]